Suggestions
Bill Plovanic
Bill Plovanic is a seasoned professional with a strong background in the medical technology sector.
He serves as the Managing Director and Equity Research Medical Technology Analyst at Canaccord Genuity - Global Capital Markets.
Previously, he held various positions at Obalon Therapeutics, including President, CEO, and Chief Financial Officer.
Bill Plovanic also has experience as a Board Member at Obalon Therapeutics and served as Managing Director of Equity Research at First Albany Capital.
His diverse roles have provided him with a comprehensive understanding of the medical technology industry and financial markets.